BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Milestone Scientific (MS) Announces Partnership Agreement With the University of Florida


10/16/2012 9:56:54 AM

LIVINGSTON, NJ--(Marketwire - October 16, 2012) - Milestone Scientific Inc. (OTCQB: MLSS), the recognized leader in advanced, computer-controlled injection technologies, today announced that it has entered into an educational partnership with the University of Florida College of Dentistry, whereby Milestone will supply its STA Single Tooth Anesthesia System® (STA System) for use by the university faculty to train students. Milestone will provide ongoing training support for the university faculty and its students.

The University of Florida College of Dentistry is one of six health colleges at the UF&Shands Academic Health Center in Gainesville, Fla. The college is the only state-sponsored dental school in Florida and is a national leader in dental education, research and service. As of 2012, 329 D.M.D. students and 133 residents were enrolled in the college. Since 1972 the college has graduated 2,423 dentists. The college operates dental centers that train dental students and residents in four Florida cities and, together, they provided more than 110,000 patient visits last year. Hialeah Dental Clinic averages 200 patients weekly providing comprehensive oral care to children, adults and senior citizens.

Ulrich Foerster, D.D.S., an associate professor in the UF Department of Oral and Maxillofacial Surgery, said, "Emerging technologies have an enormous impact on our curriculum because we have to train tomorrow's dentists on tomorrow's instruments and technologies to ensure they are prepared for a modern day dental practice. The computerized injection technology may provide clinical benefits for patients in addition to a more comfortable and safe procedure. Working with Milestone and the STA System adds value to our students' learning experience and places us at the forefront of an innovative method for achieving pain free drug delivery."

Leonard Osser, Chief Executive Officer of Milestone Scientific, said, "We look forward to our partnership with the University of Florida College of Dentistry, which is further illustration that our technology is becoming the standard of care in dental anesthesia. An important aspect of our growth strategy is working with dental universities to train and educate the next generation of dentists."

About Milestone Scientific Inc.

Headquartered in Livingston, New Jersey, Milestone Scientific is engaged in pioneering advanced computer-controlled drug delivery technologies for the medical and dental markets and currently sells its award-winning products through a global distribution network serving North and South America, Asia, Africa, Europe and the Middle East. For more information on the STA Single Tooth Anesthesia System® instrument and other innovative Milestone products, please visit the Company's web site found at www.milestonescientific.com.

SafeHarbor Statement
This press release contains forward-looking statements regarding the timing and financial impact of Milestone's ability to implement its business plan, expected revenues and future success. These statements involve a number of risks and uncertainties and are based on assumptions involving judgments with respect to future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond Milestone's control. Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, failure to achieve expected revenue growth, changes in our operating expenses, adverse patent rulings, FDA or legal developments, competitive pressures, changes in customer and market requirements and standards, and the risk factors detailed from time to time in Milestone's periodic filings with the Securities and Exchange Commission, including without limitation, Milestone's Annual Report for the year ended December 31, 2011. The forward looking-statements in this press release are based upon management's reasonable belief as of the date hereof. Milestone undertakes no obligation to revise or update publicly any forward-looking statements for any reason.


Contact:
David Waldman or Natalya Rudman
Crescendo Communications, LLC
Email: Email Contact
Tel: 212-671-1020



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES